RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Cytodyn -financingAs per website they are still at preclinical stage in cancer program and the trial is expected to begin in q2?
The website and news section is the main source of information for THTX, the idea is to make it easy for interested folks to get a decent understanding of where the company is in terms of their business not conflicting messages!! Again how hard is it to correct that for a company which is supposed to be a " growing their business to become a significant player in the pharma industry"? Some say website is not important, we need hard data, results will sell themselves etc...
I believe a low valuation should be addressed by the company at at any given time until the issue is resolved. I don't look for excuses why they are undervalued but for reasons.